Boston Scientific Corp (BSX)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	39,395,000	38,078,000	37,108,000	36,669,000	35,136,000	34,043,000	33,601,000	32,892,000	32,470,000	31,948,000	32,190,000	32,337,000	32,230,000	31,877,000	31,168,000	30,900,000	30,778,000	30,845,000	30,823,000	30,113,000
Total stockholders’ equity	US$ in thousands	21,770,000	20,708,000	20,371,000	19,925,000	19,281,000	18,885,000	18,226,000	17,850,000	17,574,000	17,641,000	17,252,000	16,735,000	16,623,000	16,461,000	15,942,000	15,720,000	15,327,000	15,564,000	15,616,000	13,804,000
Financial leverage ratio		1.81	1.84	1.82	1.84	1.82	1.80	1.84	1.84	1.85	1.81	1.87	1.93	1.94	1.94	1.96	1.97	2.01	1.98	1.97	2.18

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $39,395,000K ÷ $21,770,000K
= 1.81

The financial leverage ratio of Boston Scientific Corp has fluctuated over the past few years, ranging from a high of 2.18 in March 2020 to a low of 1.80 in September 2023. Generally, a higher financial leverage ratio indicates a company is relying more on debt to finance its operations, while a lower ratio suggests a greater reliance on equity.

The trend in Boston Scientific Corp's financial leverage ratio shows a gradual decrease from 2.18 in March 2020 to 1.81 in December 2024. This could indicate that the company has been reducing its reliance on debt over time, which can be seen as a positive sign of financial stability and risk management. It is important for investors to monitor how changes in the financial leverage ratio could impact the company's financial health and ability to meet its obligations in the future.